Viewing Study NCT05665361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-02-02 @ 11:34 PM
Study NCT ID: NCT05665361
Status: RECRUITING
Last Update Posted: 2025-10-27
First Post: 2022-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Clear Cell Renal Carcinoma (Ccrcc) View
None Papillary Renal Cell Carcinoma (Prcc) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Papillary Renal Cell Carcinoma View
None Kidney Neoplasms View
None Kidney Cancer View
None Clear Cell Renal Cell Carcinoma View
None Translocation Renal Cell Carcinoma View
None TFE3-rearranged renal cell cancer View